280 related articles for article (PubMed ID: 27852308)
1. Systems analysis identifies miR-29b regulation of invasiveness in melanoma.
Andrews MC; Cursons J; Hurley DG; Anaka M; Cebon JS; Behren A; Crampin EJ
Mol Cancer; 2016 Nov; 15(1):72. PubMed ID: 27852308
[TBL] [Abstract][Full Text] [Related]
2. A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7.
Wang C; Gao C; Zhuang JL; Ding C; Wang Y
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2127-36. PubMed ID: 22864815
[TBL] [Abstract][Full Text] [Related]
3. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.
Mazar J; DeYoung K; Khaitan D; Meister E; Almodovar A; Goydos J; Ray A; Perera RJ
PLoS One; 2010 Nov; 5(11):e13779. PubMed ID: 21072171
[TBL] [Abstract][Full Text] [Related]
4. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
5. Identifying microRNA/mRNA dysregulations in ovarian cancer.
Miles GD; Seiler M; Rodriguez L; Rajagopal G; Bhanot G
BMC Res Notes; 2012 Mar; 5():164. PubMed ID: 22452920
[TBL] [Abstract][Full Text] [Related]
6. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
Duhachek-Muggy S; Zolkiewska A
BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
[TBL] [Abstract][Full Text] [Related]
7. Microrna profiling analysis of differences between the melanoma of young adults and older adults.
Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC
J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635
[TBL] [Abstract][Full Text] [Related]
8. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
Martin del Campo SE; Latchana N; Levine KM; Grignol VP; Fairchild ET; Jaime-Ramirez AC; Dao TV; Karpa VI; Carson M; Ganju A; Chan AN; Carson WE
PLoS One; 2015; 10(1):e0115919. PubMed ID: 25587717
[TBL] [Abstract][Full Text] [Related]
9. Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines.
Sandhu R; Rivenbark AG; Coleman WB
Int J Oncol; 2012 Aug; 41(2):721-32. PubMed ID: 22664488
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
11. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.
Lee Y; Yang X; Huang Y; Fan H; Zhang Q; Wu Y; Li J; Hasina R; Cheng C; Lingen MW; Gerstein MB; Weichselbaum RR; Xing HR; Lussier YA
PLoS Comput Biol; 2010 Apr; 6(4):e1000730. PubMed ID: 20369013
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
[TBL] [Abstract][Full Text] [Related]
13. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
Georgantas RW; Streicher K; Luo X; Greenlees L; Zhu W; Liu Z; Brohawn P; Morehouse C; Higgs BW; Richman L; Jallal B; Yao Y; Ranade K
Pigment Cell Melanoma Res; 2014 Mar; 27(2):275-86. PubMed ID: 24289491
[TBL] [Abstract][Full Text] [Related]
15. Integrated analyses of zebrafish miRNA and mRNA expression profiles identify miR-29b and miR-223 as potential regulators of optic nerve regeneration.
Fuller-Carter PI; Carter KW; Anderson D; Harvey AR; Giles KM; Rodger J
BMC Genomics; 2015 Aug; 16(1):591. PubMed ID: 26265132
[TBL] [Abstract][Full Text] [Related]
16. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows.
Paraskevopoulou MD; Georgakilas G; Kostoulas N; Vlachos IS; Vergoulis T; Reczko M; Filippidis C; Dalamagas T; Hatzigeorgiou AG
Nucleic Acids Res; 2013 Jul; 41(Web Server issue):W169-73. PubMed ID: 23680784
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.
Bhattacharya A; Schmitz U; Wolkenhauer O; Schönherr M; Raatz Y; Kunz M
Oncogene; 2013 Jun; 32(26):3175-83. PubMed ID: 22847610
[TBL] [Abstract][Full Text] [Related]
18. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
19. New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.
Margue C; Philippidou D; Reinsbach SE; Schmitt M; Behrmann I; Kreis S
PLoS One; 2013; 8(9):e73473. PubMed ID: 24039954
[TBL] [Abstract][Full Text] [Related]
20. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
